8 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
algorithms by Global ... Chronic Obstructive Lung ... LAMA: long-acting ... #Management #Pulmonary ... #LABA #ICS #Guidelines
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
ICS: inhaled corticosteroids ... receptor antagonists; LABA ... : long-acting β2 ... #GINA #Asthma #Management ... #Algorithm #Guidelines
COPD Preferred Treatments - GOLD 2018 

COPD is a common progressive respiratory condition that can be
COPD Preferred Treatments ... Management of COPD ... According to GOLD2018 guidelines ... LAMA/LABA/ICS. ... #Management
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... of expiration; ICS ... corticosteroid; LABA ... , long-acting β2 ... #Algorithm #Management
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... goals of assessing lung ... and relief of dyspnea ... the patient’s dyspnea ... Effusions #MPE #Algorithm
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
asthma-COPD overlap; ICS ... corticosteroids; LABA ... #Diagnosis #Management ... #Differences #Algorithm ... #Treatment
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... goals of assessing lung ... and relief of dyspnea ... the patient’s dyspnea ... #Algorithm #Effusion
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
starting amiodarone treatment ... Dyspnea 3. ... failure - Infectious ... Labs: • Nonspecific ... Pulmonary #diagnosis #management